Medipharm Labs CorpTSX:LABSView on OTCQB
- LAST PRICE0.0750
- TODAY'S CHANGE (%)-0.0050 (-6.2500%)
- Bid / Lots0.0750/ 513
- Ask / Lots0.0800/ 23
- Open / Previous Close0.0750 / 0.0800
- Day Range
- 52 Week Range
- Volume120,810
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LABS |
|---|---|---|
| 09:32 ET | 11000 | 0.075 |
| 11:11 ET | 63000 | 0.075 |
| 12:41 ET | 1000 | 0.08 |
| 03:09 ET | 10000 | 0.08 |
| 03:32 ET | 29000 | 0.08 |
| 03:45 ET | 5000 | 0.075 |
Mar 27, 2024
MediPharm Labs Provides Conference Call Recording Details, from 10:54AM ET on Wednesday Mar 27, 2024 by Dow Jones
10:54AM ET on Wednesday Mar 27, 2024 by Dow JonesMediPharm Labs Reports Fourth Quarter and Full Year Results, from 6:30AM ET on Wednesday Mar 27, 2024 by Dow Jones
6:30AM ET on Wednesday Mar 27, 2024 by Dow JonesPress Release: MediPharm Labs Reports Fourth Quarter and Full Year Results, from 6:30AM ET on Wednesday Mar 27, 2024 by Dow Jones
6:30AM ET on Wednesday Mar 27, 2024 by Dow JonesPress Release: MediPharm Labs Reports Fourth Quarter and Full Year Results, from 6:30AM ET on Wednesday Mar 27, 2024 by Dow Jones
6:30AM ET on Wednesday Mar 27, 2024 by Dow Jones
Mar 25, 2024
MediPharm Labs Provides Update on German Cannabis Legalization, from 6:30AM ET on Monday Mar 25, 2024 by Dow Jones
6:30AM ET on Monday Mar 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Medipharm Labs Corp | 32.2M | -1.9x | --- |
Indiva Ltd | 11.7M | -1.3x | --- |
Avant Brands Inc | 24.2M | -2.9x | --- |
Chalice Brands Ltd | 19.4M | -1.4x | --- |
Rubicon Organics Inc | 21.0M | -11.4x | --- |
Slang Worldwide Inc | 6.8M | -0.3x | --- |
Company Information
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
Contact Information
- Headquarters
- 151 John StreetBARRIE, ON, Canada L4N 2L1
- Phone
- 705-719-7425
- Fax
- 705-719-7425
Executives
- Independent Chairman of the Board
- Chris Taves
- President, Director
- Keith Strachan
- Chief Executive Officer, Director
- David Pidduck
- Chief Financial Officer
- Greg Hunter
- Independent Director
- Michael Bumby
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $32.2M |
|---|---|
Revenue (TTM) | $33.1M |
Shares Outstanding | 404.0M |
Medipharm Labs Corp does not pay a dividend. | |
Beta | 0.95 |
EPS | $-0.04 |
Book Value | $0.13 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 1.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -41.84% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
